{"id":815418,"date":"2025-02-20T07:18:25","date_gmt":"2025-02-20T12:18:25","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\/"},"modified":"2025-02-20T07:18:25","modified_gmt":"2025-02-20T12:18:25","slug":"agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\/","title":{"rendered":"Agios to Present at the TD Cowen 45th Annual Healthcare Conference  on March 3, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">CAMBRIDGE, Mass., Feb.  20, 2025  (GLOBE NEWSWIRE) &#8212; Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that its management team is scheduled to present at the TD Cowen 45<sup>th<\/sup> Annual Healthcare Conference on Monday, March 3, 2025, at 10:30 a.m. ET.<\/p>\n<p>The live webcast will be accessible on the Investors section of the company&#8217;s website (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xh5IzUMSJSoLYlVLJOYA7adc33z1KQewG3tlhm5BCLT9tPyzSBelrq3AyIuVcVtUbwj5r7bTjXLWgxt5K0VY3KKL2Xjx8UFf_2OCjzlVbnjoJNtqdWVUbL1EgLhp2kua_LrmphtAbCT6vxcNPu0YXJQTaBpyWk_U-iNoPZIz8PKPqEdUif3PPPN8GExxznpDPRnwemk9DrbcsFaZAtv_A8bJWy1OOiMHfLbUIxcFIT8=\" rel=\"nofollow\" target=\"_blank\">www.agios.com<\/a>) under the \u201cEvents &amp; Presentations\u201d tab. A replay of the webcast will be archived on the company\u2019s website for at least two weeks following the presentation.<\/p>\n<p>\n        <strong>About Agios<\/strong><br \/>\n        <br \/>Agios is the pioneering leader in PK activation and is dedicated to developing and delivering transformative therapies for patients living with rare diseases. In the\u00a0U.S., Agios markets a first-in-class pyruvate kinase (PK) activator for adults with PK deficiency, the first disease-modifying therapy for this rare, lifelong, debilitating hemolytic anemia. Building on the company&#8217;s deep scientific expertise in classical hematology and leadership in the field of cellular metabolism and rare hematologic diseases, Agios is advancing a robust clinical pipeline of investigational medicines with programs in alpha- and beta-thalassemia, sickle cell disease, pediatric PK deficiency, myelodysplastic syndromes (MDS)-associated anemia and phenylketonuria (PKU). In addition to its clinical pipeline, Agios is advancing a preclinical TMPRSS6 siRNA as a potential treatment for polycythemia vera. For more information, please visit the company\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xh5IzUMSJSoLYlVLJOYA7cnoWN6F0Nx4o-d7CQRzuvzFMXfm2aTGOoEz9Vaj-37TGlXoE4crGYb1vW78QdcHZNN3w_xEZ7U_Ljo6BI-O_0z-ls-KMNZb7NLnlmsCn38Q-ArbJ931tMrhrk6ewxuemLZYoHRAeqyX9ZxwfbPcgJx898T2zm6-Nd6FYChKm_KXHB4TLQSIYz0vQhYvamGDPNH9bEZdRGNmuzylOKkiv5I=\" rel=\"nofollow\" target=\"_blank\">www.agios.com<\/a>.<\/p>\n<p>\n        <strong>Contacts:<\/strong>\n      <\/p>\n<p>\n        <strong>Investor Contact<br \/><\/strong>Chris Taylor, VP, Investor Relations and Corporate Communications<br \/>Agios Pharmaceuticals<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KuD045dnzFn6M3Z5jTTDTpgOfqzvVvDjtEvlpgAJj0UZlKKQyR17ibFmjIH8jxH5ai8CM9yDah4hfoVNEVOS9A==\" rel=\"nofollow\" target=\"_blank\">IR@agios.com<\/a><\/p>\n<p>\n        <strong>Media Contact <\/strong><br \/>\n        <br \/>Eamonn Nolan, Senior Director, Corporate Communications<br \/>Agios Pharmaceuticals<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nJZgjU4WoMqoSapLrdmgYktNtvOV2sWHEqtuKpdO0dz_0HUBiUxjzNHekR8H0KfHwL8vVT0B3xiqdu56uzR3fg==\" rel=\"nofollow\" target=\"_blank\">Media@agios.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTU2MSM2NzU5MzM0IzIwMDgyMTg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MGViOTAyNjgtZjM3Ni00NjgzLWE4YjAtNTMyNmUxYzNmOGM2LTEwMTk3OTE=\/tiny\/Agios-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass., Feb. 20, 2025 (GLOBE NEWSWIRE) &#8212; Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that its management team is scheduled to present at the TD Cowen 45th Annual Healthcare Conference on Monday, March 3, 2025, at 10:30 a.m. ET. The live webcast will be accessible on the Investors section of the company&#8217;s website (www.agios.com) under the \u201cEvents &amp; Presentations\u201d tab. A replay of the webcast will be archived on the company\u2019s website for at least two weeks following the presentation. About Agios Agios is the pioneering leader in PK activation and is dedicated to developing and delivering transformative therapies for patients living with rare diseases. In &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Agios to Present at the TD Cowen 45th Annual Healthcare Conference  on March 3, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-815418","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass., Feb. 20, 2025 (GLOBE NEWSWIRE) &#8212; Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that its management team is scheduled to present at the TD Cowen 45th Annual Healthcare Conference on Monday, March 3, 2025, at 10:30 a.m. ET. The live webcast will be accessible on the Investors section of the company&#8217;s website (www.agios.com) under the \u201cEvents &amp; Presentations\u201d tab. A replay of the webcast will be archived on the company\u2019s website for at least two weeks following the presentation. About Agios Agios is the pioneering leader in PK activation and is dedicated to developing and delivering transformative therapies for patients living with rare diseases. In &hellip; Continue reading &quot;Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-20T12:18:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTU2MSM2NzU5MzM0IzIwMDgyMTg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025\",\"datePublished\":\"2025-02-20T12:18:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\\\/\"},\"wordCount\":271,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTU2MSM2NzU5MzM0IzIwMDgyMTg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\\\/\",\"name\":\"Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTU2MSM2NzU5MzM0IzIwMDgyMTg=\",\"datePublished\":\"2025-02-20T12:18:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTU2MSM2NzU5MzM0IzIwMDgyMTg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTU2MSM2NzU5MzM0IzIwMDgyMTg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\/","og_locale":"en_US","og_type":"article","og_title":"Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025 - Market Newsdesk","og_description":"CAMBRIDGE, Mass., Feb. 20, 2025 (GLOBE NEWSWIRE) &#8212; Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that its management team is scheduled to present at the TD Cowen 45th Annual Healthcare Conference on Monday, March 3, 2025, at 10:30 a.m. ET. The live webcast will be accessible on the Investors section of the company&#8217;s website (www.agios.com) under the \u201cEvents &amp; Presentations\u201d tab. A replay of the webcast will be archived on the company\u2019s website for at least two weeks following the presentation. About Agios Agios is the pioneering leader in PK activation and is dedicated to developing and delivering transformative therapies for patients living with rare diseases. In &hellip; Continue reading \"Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-20T12:18:25+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTU2MSM2NzU5MzM0IzIwMDgyMTg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025","datePublished":"2025-02-20T12:18:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\/"},"wordCount":271,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTU2MSM2NzU5MzM0IzIwMDgyMTg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\/","name":"Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTU2MSM2NzU5MzM0IzIwMDgyMTg=","datePublished":"2025-02-20T12:18:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTU2MSM2NzU5MzM0IzIwMDgyMTg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTU2MSM2NzU5MzM0IzIwMDgyMTg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agios-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-march-3-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815418","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=815418"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815418\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=815418"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=815418"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=815418"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}